Freyr
End-to-End Regulatory Services for Life Sciences

The Life Sciences industry faces several existing and emerging challenges from a regulatory and compliance perspective. Organizations in the Life Sciences industry such as pharma, biotech, cosmetics, medical device, and consumer healthcare organizations need to keep pace with the market growth and address the public’s health needs, while simultaneously complying with regulatory requirements. These requirements also vary globally with every location, health authority, product category, and more. Organizations that can successfully manage these concerns can take a more proactive stance on adhering to the constantly changing regulatory landscape. This shall ultimately develop in them sustainability and a competitive advantage. Facilitating such compliance with regulatory requirements is Freyr, a leading niche, full-service global regulatory solutions and services company, founded in 2007. “Freyr offers full-spectrum, end-to-end regulatory services that span across strategy to submissions and lifecycle maintenance,” says Suren Dheenadayalan, the CEO of Freyr. The ISO 9001 and ISO 27001 certified company enables large, medium and small size global Life Sciences organizations to meet their regulatory goals around the world.

Freyr’s compliance services guide Life Sciences organizations through data requirements and integration, clinical trial phases and methodology, Unique Device Identification (UDI) requirements, and more. With a global presence across over 120 countries, Freyr is one of the few global companies to have specialized Centers of Excellence (CoEs) focusing on the entire regulatory value-chain. The CoEs comprise those for regulatory affairs, compliance, audit and validation, regulatory strategy, regulatory intelligence, regulatory labeling, regulatory medical writing, publishing & submissions, and artwork pack management.

With the regulatory affairs CoE, Freyr provides comprehensive regulatory services across the spectrum of global product development, registration, and commercialization. The company also delivers informed advice and pragmatic services to help companies successfully launch their products in new markets and maximize their products’ commercial potential and market success.

Freyr offers full-spectrum end-to-end regulatory services that span across strategy to submissions and lifecycle maintenance

Freyr’s compliance, audit and validation CoE ensures that all the processes and products of the Life Sciences organizations are aligned with applicable quality, information security, compliance, and regulatory requirements.

The regulatory strategy CoE helps Life Sciences organizations right from providing authoritative regulatory intelligence to successfully defining strategies for various Health Authority (HA) submissions to obtain quick market approvals in addition to providing legal representative services across the globe. “Freyr enables organizations to access the global markets with flawless regulatory strategies,” states Dheenadayalan.

The regulatory intelligence CoE enables Life Sciences organizations to keep abreast of the ever-changing regulatory environment. These services develop in organizations the capability to accurately address challenges while decoding local dossier requirements, new guidelines, ingredient & claim analysis, and more. For instance, Freyr’s Regulatory Market Intelligence Reports help improve new market expansion planning, decision-making, understanding the competition, and de-risking the market strategy through comparison of the strengths and weaknesses of the market. The company specializes in regulatory intelligence across domains such as drug regulatory intelligence, medical devices regulatory intelligence, nutraceuticals regulatory intelligence, and more.

These services illustrate Freyr’s comprehensive understanding of the Life Sciences compliance landscape and their capability to support the organizations in the industry in terms of satisfying regulatory requirements. Freyr’s proprietary regulatory tools are user-friendly, flexible, intuitive, ready-to-use, efficient, secured and cloud-hosted, which enables organizations to streamline all their regulatory activities.

The Life Sciences market is growing and is expected to reach $4,200 Mn by the end of 2024. Catering to the growing market, Freyr’s global team of skilled and experienced regulatory professionals with a deep understanding of regional/ local regulations enable Life Sciences organizations to rapidly expand to new markets. The company is a trusted partner to clients comprising Fortune 500 healthcare/life sciences, mid-market $1+ Bn biopharma, and small-medium sized companies, CROs, and more, boosting Freyr’s unceasing growth.